Amicus Therapeutics/$FOLD
About Amicus Therapeutics
Ticker
Industry
Employees
FOLD Metrics
$2.8B
-
-$0.35
0.67
-
Price and volume
Market cap
$2.8B
Beta
0.67
52-week high
$14.03
52-week low
$8.79
Average daily volume
2.5M
Financial strength
Current ratio
3.152
Quick ratio
2.2
Long term debt to equity
243.879
Total debt to equity
248.655
Interest coverage (TTM)
0.29%
Management effectiveness
Return on assets (TTM)
1.16%
Return on equity (TTM)
-67.09%
Valuation
Price to revenue (TTM)
5.666
Price to book
15.42
Price to tangible book (TTM)
-74.52
Price to free cash flow (TTM)
-88.754
Growth
Revenue change (TTM)
32.58%
Earnings per share change (TTM)
-41.96%
3-year revenue growth (CAGR)
18.87%
3-year earnings per share growth (CAGR)
-27.34%
What the Analysts think about FOLD
Analyst Ratings
FOLD Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
FOLD Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
FOLD News
FAQs
What’s the current market cap for Amicus Therapeutics stock?
What is the P/E ratio for Amicus Therapeutics stock?
Does Amicus Therapeutics stock pay dividends?
No, Amicus Therapeutics (FOLD) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Amicus Therapeutics dividend payment date?
Amicus Therapeutics (FOLD) stock does not pay dividends to its shareholders.
What is the beta indicator for Amicus Therapeutics?
Amicus Therapeutics (FOLD) has a beta rating of 0.67. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.